Clinical assessment of lorazepam in neurotic out-patients in Thailand.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D007046:Hysteria / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010044:Outpatient Clinics, Hospital; D011569:Psychiatric Status Rating Scales; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D013785:Thailand; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D014149:Tranquilizing Agents